Application 205832

Type
NDA
Sponsor
BOEHRINGER INGELHEIM

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OFEVNINTEDANIB ESYLATECAPSULE;ORALEQ 100MG BASEYesNo
002OFEVNINTEDANIB ESYLATECAPSULE;ORALEQ 150MG BASEYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N205832-001OFEVNINTEDANIB ESYLATEEQ 100MG BASECAPSULE / ORALABRLD2014-10-15
N205832-002OFEVNINTEDANIB ESYLATEEQ 150MG BASECAPSULE / ORALABRLD, RS2014-10-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
N205832-001AB
N205832-002AB

Orange Book patents#

Current patent rows page 1 of 1 · 16 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N205832-00167621802025-10-01Drug substance, Drug product2014-10-22
N205832-001101549902026-01-08U-26202019-09-18
N205832-0016762180*PED2026-04-01Pediatric extension
N205832-00110154990*PED2026-07-08Pediatric extension
N205832-001101053232029-06-04Drug product2018-11-06
N205832-00199077562029-06-07Drug product2018-04-04
N205832-00110105323*PED2029-12-04Pediatric extension
N205832-0019907756*PED2029-12-07Pediatric extension
N205832-00267621802025-10-01Drug substance, Drug product2014-10-22
N205832-002101549902026-01-08U-26202019-09-18
N205832-0026762180*PED2026-04-01Pediatric extension
N205832-00210154990*PED2026-07-08Pediatric extension
N205832-002101053232029-06-04Drug product2018-11-06
N205832-00299077562029-06-07Drug product2018-04-04
N205832-00210105323*PED2029-12-04Pediatric extension
N205832-0029907756*PED2029-12-07Pediatric extension

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 4 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
N205832-001ODE-2612026-09-06
N205832-001PED2027-03-06
N205832-002ODE-2612026-09-06
N205832-002PED2027-03-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N205832-001OFEVEQ 100MG BASECAPSULE / ORALABRLD2014-10-15a50c72e98297…
2026-08-01 22:54:322026-06N205832-002OFEVEQ 150MG BASECAPSULE / ORALABRLD, RS2014-10-15a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06N205832-001AB1a50c72e98297…
2026-08-01 22:54:322026-06N205832-002AB1a50c72e98297…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-08-01 22:54:322026-06N205832-00167621802025-10-01Drug substance, Drug product2014-10-22a50c72e98297…
2026-08-01 22:54:322026-06N205832-001101549902026-01-08U-26202019-09-18a50c72e98297…
2026-08-01 22:54:322026-06N205832-0016762180*PED2026-04-01Pediatric extensiona50c72e98297…
2026-08-01 22:54:322026-06N205832-00110154990*PED2026-07-08Pediatric extensiona50c72e98297…
2026-08-01 22:54:322026-06N205832-001101053232029-06-04Drug product2018-11-06a50c72e98297…
2026-08-01 22:54:322026-06N205832-00199077562029-06-07Drug product2018-04-04a50c72e98297…
2026-08-01 22:54:322026-06N205832-00110105323*PED2029-12-04Pediatric extensiona50c72e98297…
2026-08-01 22:54:322026-06N205832-0019907756*PED2029-12-07Pediatric extensiona50c72e98297…
2026-08-01 22:54:322026-06N205832-00267621802025-10-01Drug substance, Drug product2014-10-22a50c72e98297…
2026-08-01 22:54:322026-06N205832-002101549902026-01-08U-26202019-09-18a50c72e98297…
2026-08-01 22:54:322026-06N205832-0026762180*PED2026-04-01Pediatric extensiona50c72e98297…
2026-08-01 22:54:322026-06N205832-00210154990*PED2026-07-08Pediatric extensiona50c72e98297…
2026-08-01 22:54:322026-06N205832-002101053232029-06-04Drug product2018-11-06a50c72e98297…
2026-08-01 22:54:322026-06N205832-00299077562029-06-07Drug product2018-04-04a50c72e98297…
2026-08-01 22:54:322026-06N205832-00210105323*PED2029-12-04Pediatric extensiona50c72e98297…
2026-08-01 22:54:322026-06N205832-0029907756*PED2029-12-07Pediatric extensiona50c72e98297…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-08-01 22:54:322026-06N205832-001ODE-2612026-09-06a50c72e98297…
2026-08-01 22:54:322026-06N205832-001PED2027-03-06a50c72e98297…
2026-08-01 22:54:322026-06N205832-002ODE-2612026-09-06a50c72e98297…
2026-08-01 22:54:322026-06N205832-002PED2027-03-06a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OfevNINTEDANIBBoehringer Ingelheim Pharmaceuticals, Inc.da1c9f37-779e-4682-816f-93d0faa4cfc92025-11-20Warnings, Adverse reactionsExact identifier
application applno (NDA): 205832
application number: NDA205832
ndc (product): 0597-0143
ndc (product): 0597-0145

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 12 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0597-0143OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0143OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0143OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0143OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0143OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0143OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0145OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0145OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0145OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0145OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0145OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0145OfevnintedanibBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
79904SUPPL 2024-10-15
79879SUPPL 2024-10-14
78855SUPPL 2024-06-20
78849SUPPL 2024-06-20
71489SUPPL2022-06-30
69916SUPPL2022-01-19
69892SUPPL2022-01-18
65117SUPPL2020-11-02
65080SUPPL2020-10-30
62188SUPPL2020-03-18
62101SUPPL2020-03-10
62095SUPPL2020-03-09
59951SUPPL2019-09-10
59942SUPPL2019-09-09
56471SUPPL2018-11-15
56415SUPPL2018-11-12
52272SUPPL2018-02-02
52081SUPPL2018-01-30
50753SUPPL2017-12-18
50679SUPPL2017-12-13
49362SUPPL2017-08-15
49276SUPPL2017-08-08
47176SUPPL2017-02-13
47168SUPPL2017-02-10
19688SUPPL2016-03-04
10508SUPPL2016-02-05
24507ORIG2014-12-17
23005ORIG2014-11-21
10507ORIG2014-10-21
19687ORIG2014-10-16